Mapping of the FGFR2/FGFR3 cancer mutations onto the crystal structures and conformational dynamics profiles demonstrated that mutations are broadly distributed in the kinase domain occupying different segments (Figure 10). The gene discussed is FGFR3; the disease is cancer.